Discontinued — last reported Q2 '24
Idexx Laboratories Unrecognized compensation cost related to non-vested awards increased by 48.8% to $120.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.2%, from $108.30M to $120.40M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increasing balance suggests higher future non-cash compensation expenses, potentially impacting future earnings, while a decreasing balance indicates a reduction in future stock-based compensation drag.
This figure represents the total unrecognized compensation expense for equity-based awards granted to employees that hav...
Standard disclosure for all public companies using equity-based compensation; comparable across the asset management sector.
other_employee_service_share_based_compensation_nonveste_67563f| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $80.90M | $72.60M | $98.70M | $87.20M | $75.70M | $106.60M | $94.30M | $76.00M | $107.20M | $95.60M | $81.00M | $108.30M | $94.70M | $80.90M | $120.40M |
| QoQ Change | — | -10.3% | +36.0% | -11.7% | -13.2% | +40.8% | -11.5% | -19.4% | +41.1% | -10.8% | -15.3% | +33.7% | -12.6% | -14.6% | +48.8% |
| YoY Change | — | — | — | +7.8% | +4.3% | +8.0% | +8.1% | +0.4% | +0.6% | +1.4% | +6.6% | +1.0% | -0.9% | -0.1% | +11.2% |